20.59.Z - Manufacture of other chemical products, not elsewhere classified
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
26.60.Z - Manufacture of irradiation equipment, electromedical and electrotherapeutic equipment
32.50.Z - Production of medical devices, instruments, and products, including dental products
32.99.Z - Production of other products not classified elsewhere
33.13.Z - Repair and maintenance of electronic and optical devices
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.52.Z - Wholesale trade
69.20.Z - Accounting, bookkeeping and tax consultancy
72.19.Z - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 29,1 | 26 | 28,2 | 8,3 |
EBITDA | 38,6 | 35,9 | 35 | -2,5 |
Short time liabilities | 49,6 | 41,9 | 56,2 | 34,2 |
Equity capital | 181,9 | 225,4 | 248,3 | 10,2 |
Operating profit (EBIT) | 29,9 | 26,9 | 24,9 | -7,4 |
Assets | 238,1 | 275 | 313,7 | 14 |
Net profit (loss) | 23,9 | 43,4 | 22,9 | -47,2 |
Cash | 8,9 | 58,7 | 41,4 | -29,5 |
Net income from sale | 220,9 | 269,2 | 293,2 | 8,9 |
Liabilities and provisions for liabilities | 56,1 | 49,7 | 65,4 | 31,6 |
Working assets | 99,9 | 104,7 | 143,5 | 37,1 |
Depreciation | 8,6 | 8,9 | 10 | 12,2 |
% | % | % | p.p. | |
Profitability of capital | 13,1 | 19,3 | 9,2 | -10,1 |
Equity capital to total assets | 76,4 | 81,9 | 79,2 | -2,7 |
Gross profit margin | 13,2 | 9,7 | 9,6 | -0,1 |
EBITDA Margin | 17,5 | 13,3 | 11,9 | -1,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 82 | 57 | 70 | 13 |
Current financial liquidity indicator | 1.8013194799423218 | 2.138251543045044 | 2.223771333694458 | 0,1 |
Net dept to EBITDA | -0.23048405349254608 | -1.636838674545288 | -1.1845885515213013 | 0,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane